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Extramedullary plasmacytoma involving the heart is extremely rare. Primary extramedullary localizations are most commonly
foundintheheadandneckregion,withnoradiologicevidenceofadditionalskeletallesionsandnormalbonemarrowexamination,
but can occur in many other locations. They rarely occur in the heart and are commonly associated with multiple myeloma
diagnosis. Here, we describe a case of primary extramedullary plasmacytoma of the heart in a 62-year-old man who presented
with nocturnal dyspnea, arthralgia, and weakness. The symptoms can sometimes result from the mass effect on cardiac flow. The
diagnosisandmanagementrequirethesamerangeofclinicalandlaboratoryexpertiseasforpatientswithmultiplemyeloma.Their
management is particularly challenging due to the lack of evidence or the presence of nonspecific symptoms. The case is presented
as a learning point to remember to include plasmacytic tumors in the differential diagnosis of anaplastic tumors, even in unusual
locations, such as the heart.
1. Introduction
Plasma cell neoplasms can present clinically in a heteroge-
neous fashion. Multiple myeloma (MM), the most common
form, is a bone marrow-based, disseminated neoplasm that
is usually associated with a wide spectrum of clinical, labo-
ratory, and radiologic abnormalities. Uncommonly, a plasma
cell neoplasm can be localized and is known as primary
extramedullary plasmacytoma (EMP), with no radiologic
evidence of additional skeletal lesions and normal bone
marrow examination [1] presenting diagnostic challenges
because of its unusual location and nonspecific or absent
symptoms, but it may be present manifestation of multiple
myeloma (secondary EMP).
Primary EMP develops due to uncontrolled plasma cell
proliferation and monoclonal plasmacytic infiltration [2].
The more common form is solitary osseous plasmacytoma,
without an increase in plasma cells in random bone marrow
samples. The other form of EMP occurs at extraskeletal sites
commonly in the head and neck, with normal bone marrow
biopsies and skeletal radiographs [3].
Primary localization in the heart is an extremely rare
malignant neoplasm of the soft tissues representing 3% of
plasma cell neoplasms and less than 1% of all head and neck
malignancies [4].
The symptoms can sometimes result from the mass effect
on cardiac flow. The diagnosis and management require the
samerangeofclinicalandlaboratoryexpertiseasforpatients
with MM [5]. The treatment of these patients required a
close cooperation between cancer, radiotherapy specialists,
and hematologists that cooperation was crucial for planning
optimum care. The present study reports a case of primary
cardiac plasmacytoma in a 62-year-old male patient.
2. Case Report
A 62-year-old male, nonsmoker, was admitted to the “Tor
Vergata University Hospital” of Rome, Italy, because of
an increasing paroxysmal nocturnal dyspnea, arthralgia,
and weakness. Physical examination revealed no significant2 Case Reports in Radiology
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Figure 1: (a) Coronal reconstruction; (b) sagittal reconstruction. CT shows the presence of a 119.2mm × 124.4mm right atrium myocardial
mass, involving the auricle and the atrial septum.
(a) (b)
Figure 2: (a) Sagittal reconstruction; (b) coronal reconstruction. CT shows the presence of right atrium myocardial mass and no other
abnormality in other organs.
hemodynamic derangement with a pulmonary ejection mur-
mur and accentuated pulmonic second sound. Electrocar-
diography was only significant for sinus tachycardia. No
lymphadenopathieswerefoundontheneckandinaxillaeand
groins.
Serum immunoglobulin quantitation showed minimal
increased IgG (1398mg/dL versus normal 543–1360mg/dL)
and IgA (280mg/dL versus normal 58–259mg/dL). The
urineproteinwasnormal115mg/24h(normal:0–150).Other
laboratory tests showed erythrocyte sedimentation rate to
be 13mm/h (normal: 0–15) and C reactive protein to be
0.6mg/dL (normal: <0.9).
Chest radiography demonstrated a slightly enlarged car-
diac silhouette with signs of pulmonary hypertension and
congestion with a bilateral small pleural effusion.
A transthoracic echocardiogram (TTE) revealed a large
right atrial mass with minimal pericardial effusion. Left and
right ventricular functions were within normal ranges, and
both aortic and mitral valvular leaflets were focally calcified
with no insufficiency or stenosis.
A multislice computed tomography (CT) exam with
contrast media confirmed the presence of a 3.2cm × 2.8cm
right atrium myocardial mass, involving the auricle and the
atrial septum (Figures 1 and 2). No enlarged lymph nodes
were present in the mediastinum, no osteolytic bone lesions
w e r en o t e di nt h o r a c i ca n dl u m b a rv e r t e b r a e ,a n dn oo t h e r
a b n o r m a l i t i e sw e r eo b s e rv e di no t h e ro r g a n s .
The clinical and diagnostic imaging findings suggested
an occult primary malignancy with metastases to the heart,
but subsequent clinical investigations revealed no primary
malignancies. The transesophageal echocardiography (TEE)
confirmed the presence of a large dishomogeneous myocar-
dial mass involving the endocardial surface which was
successfully aspirated with the EUS-FNA echoendoscope.Case Reports in Radiology 3
The cytology of the right atrial mass revealed a hypercellular
m a l i g n a n tn e o p l a s mw i t hs o m ea t y p i c a lp o l y h e d r a lc e l l s
consistent with immature plasmacytoid cells suspicious for
EMP or MM. Immunohistochemical assays demonstrated
positive expression for the antibodies CD138, kappa chain
clonality, and epithelial membrane antigen (EMA) with
plasmacytoma features. The iliac bone marrow biopsy was
normal, and no increased lymphocytes and plasma cells were
seen. No osteolytic bone lesions were detected. A normal
level of monoclonalprotein in serum and urinary(24h urine
sample) electrophoresis with immunofixation confirmed the
absence of occult disease elsewhere. Bence Jones protein
test was negative. The absence of lymphadenopathy and
hepatosplenomegaly helped to rule out a B-cell lymphoma.
A hybrid positron emission tomography- (PET-) computed
tomography (CT) scan showed an abnormal uptake in the
expectedmyocardiallocation,anddiagnosisofprimaryEMP
of the heart was made. The patient underwent a treatment
with 45Gy of localized radiation for five consecutive weeks
w i t hh i g h - d o s ec o r t i c o s t e r o i d s .Th em a s sd i m e n s i o ns u g -
gested the clinical necessity of supporting the radiotherapy
with a consolidation chemotherapy regimen.
3. Discussion
Primary cardiac involvement in plasma cellular tumor is
uncommon, and only a few cases with clinical significance
have been reported. Primary EMP is an exceedingly rare
neoplasm, and only few cases involving the atria have been
encountered in the English-language literature [2]. Interest-
ingly, all cases involved one atrium or both atria, presenting
as large space-occupying tumors, causing cardiovascular
compromise. Pericardial effusion also developed in some
cases and caused cardiovascular dysfunction.
Diagnosis of EMP requires histologic and immune his-
tochemical confirmations and an absence of MM, solitary
osseous plasmacytoma, and plasmacytoma arising in other
anatomic locations.
The tumor is composed of a monoclonal proliferation
of plasma cells that may show cytological atypia mimicking
a large cell lymphoma, poorly differentiated carcinoma,
extramedullary myeloid cell tumor [6], or melanoma.
Myxoma, metastatic malignancies other than plasmacy-
toma, or less frequently sarcomas are much more commonly
seen in the heart than plasmacytoma. As a result, the
differential diagnosis may be overlooked unless a pathologist
has a high degree of suspicion [5].
Probably an MRI mediastinum study with ECG syn-
chronized sequences could help us to exactly detect the
relationships with the myocardium, but a heart assessment
was performed by TTE to evaluate cardiac function, so
M R Ii nt h i sc a s es h o u l dn o ta d da n yf u r t h e ri n f o r m a t i o n
f o ri m p r o v i n gt h et h e r a p e u t i c a la p p r o a c h .Th eo n l yc l i n i c a l
findingsandconventionalimagingstudiesusuallyperformed
for the MM diagnosis did not draw exactly the patient
pathologic outline.
Only the CT study gave us the correct information
about the solitary presentation of the plasmacytoma, and
a tt h es a m et i m ew ew e r ea b l et ou n d e r s t a n dt h ea n a t o m i c
relationship with the heart.
The PET-CT study was above all important to study the
active lesion metabolism and also to confirm the CT finding
of solitary extramedullary mass.
This is a very important aspect considering the treatment
choice. In this case the patient underwent radiotherapy, and
the mass dimensions (very well obtained by multiplanar
CT reconstruction) suggested introducing the patient to
chemotherapy too.
4. Conclusions
The CT role in the diagnosis of solitary EMP in our expe-
rience was fundamental to correctly diagnose this finding,
influencing the patient treatment. PET-CT total body scan
was useful to confirm no evidence of more foci in the whole
body and gave us important information about localization,
dimensions, and vascularization.
Probably an MRI mediastinum study with ECG syn-
chronized sequences could help us to exactly detect the
relationships with the myocardium, but a heart assessment
wasperformedbyTTEtoevaluatecardiacfunction,CTstudy
could not settle the differential diagnosis, but thanks to its
feasibility, rapidity and no invasive technique, detecting the
EMP was very important in our work.
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